NASDAQ:TLRY (Tilray)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Tilray (NASDAQ: TLRY) Latest News

Investing
Is This the End for Marijuana Stocks?

Bank Stocks
Should You Buy Tilray (NASDAQ:TLRY) or Royal Bank of Canada (TSX:RY) Stock Today?

Top TSX Stocks
Is an Even Bigger Marijuana Stock Crash Coming?
Investing
Would Warren Buffett Buy Marijuana Stocks?

Top TSX Stocks
Why Is Andrew Left Shorting Canopy Growth Corp (TSX:WEED) Stock?
Investing
Is It Time to Buy Aurora Cannabis (TSX:ACB) or Tilray (NASDAQ:TLRY) Stock?

Investing
Should Aurora Cannabis (TSX:ACB) or Tilray Inc. (NASDAQ:TLRY) Stock Be on Your Buy List?

Investing
Is the Cannabis Bubble Finally Popping?

Investing
2 Top Marijuana Stocks With Great Buy-and-Hold Appeal

Investing
Is HEXO Corp. (TSX:HEXO) or Tilray Inc. (NASDAQ:TLRY) Stock a Buy Right Now?
Tech Stocks
Investors Should Swap Out Canadian Cannabis for Quality Growth Stocks
